3637 results for «50»
3637 results
Complex distal LM PCI challenges (trifurcations and more)
20 May 2026 – From EuroPCR 2026
Focusing on the intricacies of complex distal left main PCI, this session covers challenging trifurcation lesions and emergency interventions. It includes IVUS-guided approaches for trifurcation PCI, management of calcified left main trifurcations, and multidisciplinary team rescue strategies for unstable left main bifurcation disease.
DCB - Going beyond in-stent restenosis
20 May 2026 – From EuroPCR 2026
This session examines the expanding role of drug-coated balloons (DCB) beyond in-stent restenosis, including treatment of acute coronary syndromes, calcified lesions, and bifurcations. It reviews current evidence supporting DCB-based revascularization and outlines essential procedural steps to optimize outcomes.
When the angiogram shows no answer for your AMI patient: what's next?
20 May 2026 – From EuroPCR 2026
This session focuses on non-occlusive causes of acute coronary syndromes (ACS) when angiograms do not reveal clear pathology. It emphasizes the diagnostic value of intracoronary imaging for conditions such as MINOCA and spontaneous coronary artery dissection (SCAD), and discusses optimal treatment strategies and prognostic considerations.
Mitral valve-in-valve, valve-in-ring, valve-in-mac: the good, the bad and the ugly
20 May 2026 – From EuroPCR 2026
This session delves into the complexities of mitral valve interventions, focusing on valve-in-valve, valve-in-ring, and valve-in-mitral annular calcification (MAC) procedures. It addresses troubleshooting in high-risk valve-in-MAC cases, urgent transcatheter mitral valve implantation supported by microaxial flow pumps, challenges in delivering balloon expandable valves transeptally, and innovative...
Imaging to the rescue in LAA closure
20 May 2026 – From EuroPCR 2026
This session highlights the pivotal role of advanced imaging modalities in left atrial appendage (LAA) closure. Topics include novel risk assessment workflows for air embolism, evaluation protocols using cardiac CT and 3D TEE, reproducibility of anatomical classifications, and long-term follow-up outcomes with various imaging techniques.
New tools for risk stratification in STEMI
20 May 2026 – From EuroPCR 2026
This session highlights novel tools and scores for risk stratification in ST-elevation myocardial infarction (STEMI) patients. It covers prognostic indices such as the index of microcirculatory resistance, the PREDICT-STEMI score, thrombus characteristics, sex differences in outcomes, renal impairment impacts, and benefits of complete revascularization strategies.
Navigating the complexity of high bleeding risk
20 May 2026 – From EuroPCR 2026
Focusing on patients with high bleeding risk undergoing PCI, this session presents contemporary evidence on prevalence, procedural strategies with different stent types, antiplatelet therapy considerations including diabetic and sex-specific outcomes, and novel technologies such as sirolimus-coated balloons and machine learning models for restenosis prediction.
Cardiogenic shock: identifying the cause and tailoring the treatment
20 May 2026 – From EuroPCR 2026
This session focuses on the critical evaluation and management of cardiogenic shock by identifying its underlying causes and tailoring treatment accordingly. It presents complex cases including free wall rupture bail-out strategies, management dilemmas in inferior STEMI complicated by incomplete ventricular rupture, multifactorial culprit lesions, refractory hypotension...
Registries and trials in TMVR
20 May 2026 – From EuroPCR 2026
This session provides an in-depth review of registries and clinical trials focused on transcatheter mitral valve replacement (TMVR). It presents data on annular and ventricular remodeling with the HighLife system, mid- to long-term valve performance, and innovations in transseptal TMVR using novel bioprostheses.
Stentless PCI, DCB and BVS in complex scenarios
20 May 2026 – From EuroPCR 2026
This session explores the use of stentless percutaneous coronary interventions (PCI) employing drug-coated balloons (DCB) and bioresorbable scaffolds (BVS) in complex coronary scenarios. Through detailed case discussions, it addresses decision-making processes, technical considerations, and practical tips for successfully completing PCI without permanent stenting.
Complications in coronary interventions
20 May 2026 – From EuroPCR 2026
This session reviews uncommon and challenging complications encountered during coronary interventions. Cases include brachial arteriovenous fistula following radial access, retained guidewires, coronary sinus perforation during device implantation, and complex atherectomy procedures, emphasizing preparedness and management strategies.
Reliability and application of angio-based physiology in daily work
20 May 2026 – From EuroPCR 2026
This session evaluates the reliability and clinical application of angiography-based physiological assessments in daily practice. Topics include comparisons of angiography-derived microvascular resistance and flow metrics with invasive methods, reproducibility of quantitative flow ratio (QFR), and its correlation with symptom burden and other imaging modalities.
When balloons fail: how to win against coronary calcium
19 May 2026 – From EuroPCR 2026
This session refines strategies to overcome undilatable calcified coronary lesions by integrating modern calcium-modification technologies into complex PCI workflows. Through multiple international case studies, it highlights approaches to achieve optimal stent expansion despite severe coronary calcium challenges.
STEMI 2026 - The precision revolution
19 May 2026 – From EuroPCR 2026
Explore the forefront of STEMI care with a focus on precision medicine, integrating artificial intelligence for pre-hospital triage, evidence-based complete revascularisation strategies, and advanced imaging guidance during primary PCI. This session also addresses tailored antithrombotic approaches, timing of mechanical support in cardiogenic shock, and management of...
Beyond the angiogram: contemporary management of STEMI
19 May 2026 – From EuroPCR 2026
This session provides an in-depth review of complex STEMI cases from diverse clinical settings, emphasizing optimisation of primary PCI strategies, complication management, and individualised antithrombotic therapy. Real-world cases from Albania, Macedonia, and Slovakia illustrate diagnostic challenges and therapeutic decision-making to improve patient outcomes.
TAVI complications and management strategies
19 May 2026 – From EuroPCR 2026
Gain comprehensive knowledge on anticipating, identifying, and managing complications during transcatheter aortic valve implantation (TAVI). Through complex international case studies—including transaxillary Navitor implantation and bicuspid aortic valve challenges—this session highlights key strategies to improve procedural safety and outcomes.
Next generation TAVI procedural planning
19 May 2026 – From EuroPCR 2026
Explore the forefront of TAVI procedural planning, featuring innovations such as valve-in-valve techniques for sutureless valves, integration of artificial intelligence in heart team decisions, and advanced imaging-guided access methods. The session also examines clinical outcomes related to bicuspid anatomy and prosthesis-patient mismatch, providing a comprehensive view...